You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

343 Results
Guidelines and Advice
Status: Current
ID: GL 8-12
Updated
Jan 2026
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Pembrolizumab - Locally Recurrent Unresectable or Metastatic Triple Negative Breast Cancer
New Drug Funding Program
    Nab-Paclitaxel - Metastatic Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab,
nab-PACLitaxel
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Feb 2026
Drug
Other Name(s): Opdivo®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jan 2026
Guidelines and Advice
Status: Current
ID: 7-11
Version: 3
Mar 2022
Guidelines and Advice
Status: Archived
ID: SCT 6
Feb 2016

Pages